Research News and Research

RSS
BUSM Professor receives funding for research on obesity in African-American women

BUSM Professor receives funding for research on obesity in African-American women

UCSF collaborates with Zcube to develop new ways to deliver drugs

UCSF collaborates with Zcube to develop new ways to deliver drugs

EDMA supports the Rare Disease Day

EDMA supports the Rare Disease Day

Apparently mindless survival strategies best for long-term success of genes

Apparently mindless survival strategies best for long-term success of genes

Obama administration awaiting next reform ruling from Florida judge

Obama administration awaiting next reform ruling from Florida judge

LWW launches Orthopaedics Network

LWW launches Orthopaedics Network

Health law ups the ante in state-federal Medicaid budget battle

Health law ups the ante in state-federal Medicaid budget battle

Regulators face challenge of defining 'essential care' benefits

Regulators face challenge of defining 'essential care' benefits

UM CAS awarded Howard Hughes Medical Institute grant

UM CAS awarded Howard Hughes Medical Institute grant

Politics play into state-level implementation issues

Politics play into state-level implementation issues

Cryo-Cell fiscal 2010 net income increases to $3.4 million

Cryo-Cell fiscal 2010 net income increases to $3.4 million

'Romneycare' continues to draw political focus

'Romneycare' continues to draw political focus

Deal to avert gov't shutdown appears within reach

Deal to avert gov't shutdown appears within reach

Viewpoints: Judge Kessler's decision; Utah is role model; Malpractice system flaws

Viewpoints: Judge Kessler's decision; Utah is role model; Malpractice system flaws

State News: N.Y. Medicaid's compromise; Va. ups health spending; Medi-Cal ruling

State News: N.Y. Medicaid's compromise; Va. ups health spending; Medi-Cal ruling

Tenofovir gel may help reduce risk of HIV from anal sex

Tenofovir gel may help reduce risk of HIV from anal sex

Endo fourth quarter total revenues increase 31% to $511 million

Endo fourth quarter total revenues increase 31% to $511 million

Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

Rexahn's novel anti-cancer quinoxalinyl-piperazine compounds granted European patent

Rexahn's novel anti-cancer quinoxalinyl-piperazine compounds granted European patent

Positive results from Trius torezolid Phase 1 lung study

Positive results from Trius torezolid Phase 1 lung study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.